MassDevice Q&A

June 30, 2009 by MassDevice staff

Q&A Features

04/03/2013 by Brian Johnson

Medical device company Entellus Medical is looking to change the standard of care in treating chronic sinusistis.

Entellus Medical

Brian Farley knows a little something about building a successful medical device company from the ground up.

Back in 1995 Farley was the 1st employee of VNUS Medical Technologies, which developed a catheter-based treatment for venous insufficiency. During his tenure as VNUS CEO, the company went public in 2004 before being acquired by Covidien (NYSE:...

03/27/2013 by Brian Johnson

Third Rock Ventures partner Neil Exter tells about the firm's latest $516 million fund, how it plans to launch 15-16 new companies in the life sciences space and how its unique investment and development strategy paves the way for success.

Third Rock Ventures partner Neil Exter

Third Rock Ventures, one of the premiere healthcare venture capital firms, is loaded for bear again.

The Boston-based VC group recently closed its 3rd fund, a $516 million tranche that will go towards launching some 15 to16 new life science companies in the coming months. In the past 6...

03/21/2013 by Brian Johnson

Bill Walton tells to about his work with medical device company NuVasive and its "Better Way Back" program.

Bill Walton

Even before the spine surgery he claims saved his life, Bill Walton's body was a marvel of medicine.

The Hall of Fame basketball player, who counts 2 NCAA national titles and 2 NBA championship rings to his name, has undergone 36 surgeries by his count, including 2 ankle fusions and a plethora of knee and foot procedures.

Despite that dubious pedigree, Walton told that he was unprepared for the overwhelming nerve pain from a degenerative...

03/11/2013 by Arezu Sarvestani

Veteran cardiologist and patient safety advocate Dr. Robert Hauser tells about his new vision for healthcare surveillance, his long struggle to spur change at the FDA and what FDA regulators can learn from aviation regulation.

Dr. Robert Hauser

Veteran cardiologist Dr. Robert Hauser is eager for change, even if he has to go straight to Capitol Hill himself to make it happen.

The patient safety advocate and vocal critic of the FDA announced at this year's American College of Cardiology conference that he's working on a proposal to...

02/13/2013 by Brian Johnson

Boston Scientific CFO Jeffrey Capello tells how the medical device company plans to pull itself out of one of the roughest patches in its history.

Boston Scientific CFO Jeffrey Capello sat down with Boston Scientific (NYSE:BSX) CFO Jeffrey Capello in New York City this...

02/12/2013 by Arezu Sarvestani

Direct Flow Medical president and CEO Bernie Lyons are betting that its heart valve technology can use the decade's worth of experience of the medical device industry's transcatheter aortic valve implant pioneers to leapfrog the competition.

Direct Flow Medical CEO Bernie Lyons

Being one of the smallest players on the field means you've got to differentiate yourself to stand out against the titans of the game, and that's what Direct Flow Medical CEO Bernie Lyons aims to do.

Direct Flow and its transcatheter aortic valve implantation technology must face down...

Syndicate content